Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

BYD’s (BYDDF) reliance on financing from working capital has masked the company’s surging debt levels, Linda Lew and Danny Lee of Bloomberg ...

BYD appears “addicted” to supply chain financing, GMT said, according to the journal. BYD put its net debt at 27.7B yuan as of mid-2024. Published first on TheFly – the ultimate source for ...